By a News Reporter-Staff News Editor at Clinical Trials Week -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, announced that it has earned CEO Cancer Gold Standard™ re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the latest, comprehensive requirements of this national workplace wellness accreditation program established by the CEO Roundtable on Cancer (see also Pharmaceutical Companies).
The CEO Roundtable on Cancer is a forum that brings together key cancer leaders from government, business, academic and non-profit sectors to develop and implement initiatives that reduce the risk of cancer, enable early diagnosis, facilitate access to the best available treatments and hasten the discovery of novel anti-cancer therapies. Founded by former President George H.W. Bush, the nonprofit organization developed and administers the Gold Standard, an employee wellness accreditation program that addresses cancer in the workplace. EMD Serono is one of nearly 200 private, nonprofit and government employers in a wide range of occupational categories that have earned Gold Standard accreditation, including the National Cancer Institute (NCI) and a number of NCI-designated cancer centers.
"Nearly all of us are impacted by cancer in some way. At EMD Serono we are committed to making a difference in the lives of patients, their loved ones and healthcare professionals, by accelerating innovation in oncology in order to develop therapies with the potential to transform the way cancer is treated," said Gary Zieziula, President and Managing Director, North America. "This commitment extends to our corporate family through employee wellness programs that are designed to help reduce the risk of cancer, promote early detection and provide quality care."
In order to earn and maintain CEO Cancer Gold Standard accreditation, EMD Serono met specific requirements in corporate culture and health benefits, including: establishing policies and programs to reduce cancer risk by prohibiting tobacco use in the workplace and supporting tobacco cessation efforts; promoting physical activity, healthy nutrition and weight management; providing health insurance options that include detecting cancer at its earliest stages, access to quality care, and participation in clinical trials; promoting employee awareness of these initiatives; and supporting the needs of cancer survivors in the workplace.
Keywords for this news article include: Pharmaceutical Companies, Oncology, Wellness, EMD Serono, Cancer Risk, Risk and Prevention.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC
(c) 2016 NewsRx LLC, source Health Newsletters